123 related articles for article (PubMed ID: 26820473)
1. Insights into the interaction of the N-terminal amyloidogenic polypeptide of ApoA-I with model cellular membranes.
Rusciano G; Pesce G; Zito G; Sasso A; Gaglione R; Del Giudice R; Piccoli R; Monti DM; Arciello A
Biochim Biophys Acta; 2016 Apr; 1860(4):795-801. PubMed ID: 26820473
[TBL] [Abstract][Full Text] [Related]
2. Amyloidogenic Mutation Promotes Fibril Formation of the N-terminal Apolipoprotein A-I on Lipid Membranes.
Mizuguchi C; Ogata F; Mikawa S; Tsuji K; Baba T; Shigenaga A; Shimanouchi T; Okuhira K; Otaka A; Saito H
J Biol Chem; 2015 Aug; 290(34):20947-20959. PubMed ID: 26175149
[TBL] [Abstract][Full Text] [Related]
3. Chameleon 'aggregation-prone' segments of apoA-I: A model of amyloid fibrils formed in apoA-I amyloidosis.
Louros NN; Tsiolaki PL; Griffin MD; Howlett GJ; Hamodrakas SJ; Iconomidou VA
Int J Biol Macromol; 2015 Aug; 79():711-8. PubMed ID: 26049118
[TBL] [Abstract][Full Text] [Related]
4. Identification of an amyloid fibril forming peptide comprising residues 46-59 of apolipoprotein A-I.
Wong YQ; Binger KJ; Howlett GJ; Griffin MD
FEBS Lett; 2012 Jun; 586(13):1754-8. PubMed ID: 22609356
[TBL] [Abstract][Full Text] [Related]
5. Effects of a lipid environment on the fibrillogenic pathway of the N-terminal polypeptide of human apolipoprotein A-I, responsible for in vivo amyloid fibril formation.
Monti DM; Guglielmi F; Monti M; Cozzolino F; Torrassa S; Relini A; Pucci P; Arciello A; Piccoli R
Eur Biophys J; 2010 Aug; 39(9):1289-99. PubMed ID: 20182709
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of aggregation and fibril formation of the amyloidogenic N-terminal fragment of apolipoprotein A-I.
Mizuguchi C; Nakagawa M; Namba N; Sakai M; Kurimitsu N; Suzuki A; Fujita K; Horiuchi S; Baba T; Ohgita T; Nishitsuji K; Saito H
J Biol Chem; 2019 Sep; 294(36):13515-13524. PubMed ID: 31341020
[TBL] [Abstract][Full Text] [Related]
7. FRET evidence for untwisting of amyloid fibrils on the surface of model membranes.
Gorbenko G; Trusova V; Girych M; Adachi E; Mizuguchi C; Akaji K; Saito H
Soft Matter; 2015 Aug; 11(31):6223-34. PubMed ID: 26153461
[TBL] [Abstract][Full Text] [Related]
8. Membrane effects of N-terminal fragment of apolipoprotein A-I: a fluorescent probe study.
Trusova V; Gorbenko G; Girych M; Adachi E; Mizuguchi C; Sood R; Kinnunen P; Saito H
J Fluoresc; 2015 Mar; 25(2):253-61. PubMed ID: 25595057
[TBL] [Abstract][Full Text] [Related]
9. Recombinant amyloidogenic domain of ApoA-I: analysis of its fibrillogenic potential.
Di Gaetano S; Guglielmi F; Arciello A; Mangione P; Monti M; Pagnozzi D; Raimondi S; Giorgetti S; Orrù S; Canale C; Pucci P; Dobson CM; Bellotti V; Piccoli R
Biochem Biophys Res Commun; 2006 Dec; 351(1):223-8. PubMed ID: 17056013
[TBL] [Abstract][Full Text] [Related]
10. The N-terminal fragment of human islet amyloid polypeptide is non-fibrillogenic in the presence of membranes and does not cause leakage of bilayers of physiologically relevant lipid composition.
Khemtémourian L; Engel MF; Liskamp RM; Höppener JW; Killian JA
Biochim Biophys Acta; 2010 Sep; 1798(9):1805-11. PubMed ID: 20570648
[TBL] [Abstract][Full Text] [Related]
11. Effect of Phosphatidylserine and Cholesterol on Membrane-mediated Fibril Formation by the N-terminal Amyloidogenic Fragment of Apolipoprotein A-I.
Mizuguchi C; Nakamura M; Kurimitsu N; Ohgita T; Nishitsuji K; Baba T; Shigenaga A; Shimanouchi T; Okuhira K; Otaka A; Saito H
Sci Rep; 2018 Apr; 8(1):5497. PubMed ID: 29615818
[TBL] [Abstract][Full Text] [Related]
12. n-Butanol partitioning and phase behavior in DPPC/DOPC membranes.
Kurniawan Y; Venkataramanan KP; Scholz C; Bothun GD
J Phys Chem B; 2012 May; 116(20):5919-24. PubMed ID: 22546177
[TBL] [Abstract][Full Text] [Related]
13. The polar nature of 7-ketocholesterol determines its location within membrane domains and the kinetics of membrane microsolubilization by apolipoprotein A-I.
Massey JB; Pownall HJ
Biochemistry; 2005 Aug; 44(30):10423-33. PubMed ID: 16042420
[TBL] [Abstract][Full Text] [Related]
14. Structural Stability and Local Dynamics in Disease-Causing Mutants of Human Apolipoprotein A-I: What Makes the Protein Amyloidogenic?
Das M; Wilson CJ; Mei X; Wales TE; Engen JR; Gursky O
J Mol Biol; 2016 Jan; 428(2 Pt B):449-62. PubMed ID: 26562506
[TBL] [Abstract][Full Text] [Related]
15. Insights into the fate of the N-terminal amyloidogenic polypeptide of ApoA-I in cultured target cells.
Arciello A; De Marco N; Del Giudice R; Guglielmi F; Pucci P; Relini A; Monti DM; Piccoli R
J Cell Mol Med; 2011 Dec; 15(12):2652-63. PubMed ID: 21306558
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein A-I induced amyloidosis.
Genschel J; Haas R; Pröpsting MJ; Schmidt HH
FEBS Lett; 1998 Jul; 430(3):145-9. PubMed ID: 9688527
[TBL] [Abstract][Full Text] [Related]
17. Molecular dynamics simulations of the interactions of DMSO with DPPC and DOPC phospholipid membranes.
Hughes ZE; Mark AE; Mancera RL
J Phys Chem B; 2012 Oct; 116(39):11911-23. PubMed ID: 22947053
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylethanolamine accelerates aggregation of the amyloidogenic N-terminal fragment of apoA-I.
Kurimitsu N; Mizuguchi C; Fujita K; Taguchi S; Ohgita T; Nishitsuji K; Shimanouchi T; Saito H
FEBS Lett; 2020 May; 594(9):1443-1452. PubMed ID: 31968125
[TBL] [Abstract][Full Text] [Related]
19. Effects of the core lipid on the energetics of binding of ApoA-I to model lipoprotein particles of different sizes.
Tanaka M; Saito H; Dhanasekaran P; Wehrli S; Handa T; Lund-Katz S; Phillips MC
Biochemistry; 2005 Aug; 44(31):10689-95. PubMed ID: 16060677
[TBL] [Abstract][Full Text] [Related]
20. Amyloid-β aggregation on model lipid membranes: an atomic force microscopy study.
Hane F; Drolle E; Gaikwad R; Faught E; Leonenko Z
J Alzheimers Dis; 2011; 26(3):485-94. PubMed ID: 21694459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
